About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Report Type
Organization
Disposition
Year
Month
Found 72804 record(s)
Req # A-2020-001456
Request for information on drug Epival. Records of companies Health Canada ordered drugs from and the contact information for same. All agreements and contracts Health Canada signed with each company supplying Canada with drug Epival.Organization: Health Canada
January 2021
Req # A-2020-001481
Obtain all correspondence / letters / study emails / research held by the Minister on problems and challenges related to recreational cannabis since its legalization, but for the period from January 1, 2020 to today, December 30, 2020.Organization: Health Canada
January 2021
Req # A-2020-001536
Any information regarding wells installed on Lac Seul First Nation Reserve 28 that are present on the north east corner of Frenchmans Head Road and Kejick Bay Road on the Lac Seul First Nation. In relation to a Phase I ESA and any information…Organization: Health Canada
January 2021
Req # A-2016-001747
Adverse Reaction Reports (AERs) for Diclectin. Report numbers: 000541568, 000640670, 000669055, 000669179, 00670872, 000678548, E2B_00575826, E2B_00593257, E2B_00709057.Organization: Health Canada
January 2021
Req # A-2019-000282
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 18-119991-639.Organization: Health Canada
January 2021
Req # A-2019-000940
Adverse Reaction Reports (AERs). Report numbers: E2B_00815168, E2B_01261767, E2B_01639359, E2B_01893840, E2B_01836677, E2B_01610888, E2B_01706029, E2B_01708701, 000657419, E2B_02053529, 000491763, E2B_00034322, E2B_00034281, 000491772.Organization: Health Canada
January 2021
Req # A-2019-001190
Adverse Reaction Reports (AERs) for HYDROXYCHLOROQUINE SULFATE. Report numbers: E2B_02037310, E2B_02127356, E2B_02128458, E2B_02130341, 000718772, E2B_02174782, 000718874, E2B_02225719, E2B_02225758, E2B_02180913, 000712978, 000719648, 000719746,…Organization: Health Canada
January 2021
Req # A-2019-001191
Adverse Reaction Reports (AERs) for HYDROXYCHLOROQUINE SULFATE. Report numbers: E2B_02139188, E2B_02096775, E2B_02101008, E2B_02102951, E2B_02123298, E2B_02123654, E2B_02123790, E2B_02123841, E2B_02134309, E2B_01995214, E2B_02139539, E2B_01990951,…Organization: Health Canada
January 2021
Req # A-2019-001360
Adverse Reaction Report (AER). Report number: E2B_02492809.Organization: Health Canada
January 2021
Req # A-2019-001364
Adverse Reaction Reports (AERs). Report numbers: E2B_02475471, E2B_02414940.Organization: Health Canada
January 2021